Souhaitez-vous accéder aux communiqués récents ?

THE WOODLANDS, TX, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to...

Live video webcast on Wednesday, January 22nd at 4:00 PM ET THE WOODLANDS, TX, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical...

Olo, a mental wellness platform, unveiled its science-backed audio journeys for stress relief and nervous system resilience at Slush 2024.

The study aims to determine if filtered music as an adjunct therapy can reduce PTSD symptoms and enhance treatment for civilian and military populations.

Management to host live webcast to discuss results on Tuesday, June 18th at 8:30 a.m. ET THE WOODLANDS, TX, June 10, 2024 (GLOBE NEWSWIRE) -- – Autonomix Medical, Inc. (NASDAQ: AMIX)...

Live webcast with Lori Bisson, Chief Executive Officer of Autonomix, on Thursday, February 29th at 12:00 PM ET THE WOODLANDS, TX, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ:...

Vancouver, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The global neuroprosthetics market size was USD 10.48 Billion in 2022 and is expected to register a rapid revenue CAGR of 12.4% during the forecast...

Live moderated video webcast on Monday, December 11 at 2:00 PM ET THE WOODLANDS, TX, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device...

New York, Sept. 02, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Nerve Repair & Regeneration Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...

PHOENIX, July 22, 2020 (GLOBE NEWSWIRE) -- The Evolution Code, a program focused on the nervous system and proven to increase performance and decrease the risk of injury, today announces its...